Novel sublingual tablets of Atorvastatin calcium/Trimetazidine hydrochloride combination; HPTLC quantification, in vitro formulation and characterization

Novel sublingual tablets of Atorvastatin calcium/Trimetazidine hydrochloride combination; HPTLC quantification, in vitro formulation and characterization

Background: Ischemic heart disorders and accumulation of lipids in blood vessels could contribute to angina pectoris. Therefore, the aim of this study was to formulate sublingual tablets containing a novel combination of Atorvastatin calcium (ATOR) and Trimetazidine HCl (TMZ) for efficient treatment...

Full description

Bibliographic Details
Main Authors: Noha N. Atia, Hesham M. Tawfeek, Azza H. Rageh, Marwa R. El-Zahry, Ahmed Abdelfattah, Mahmoud A. Younis
Format: Article
Language:English
Published: Elsevier 2019-05-01
Series:Saudi Pharmaceutical Journal
Online Access:http://www.sciencedirect.com/science/article/pii/S1319016418303396

Internet

http://www.sciencedirect.com/science/article/pii/S1319016418303396

Similar Items